Skip to main content
Theralase Technologies Inc. logo

Theralase Technologies Inc. — Investor Relations & Filings

Ticker · TLT ISIN · CA88337V1004 LEI · 529900NI3Y8GLE2IBF28 TSXV Manufacturing
Open in API
Filings indexed 698 across all filing types
Latest filing 2025-07-07 Capital/Financing Update
Country CA Canada
Listing TSXV TLT

About Theralase Technologies Inc.

https://theralase.com/

Theralase Technologies Inc. designs, develops, manufactures, and markets patented laser technology platforms for both bio-stimulative and bio-destructive medical applications. The company operates two core divisions. The first is Cool Laser Therapy (CLT), which utilizes proprietary super-pulsed laser systems for therapeutic purposes, focusing on pain management, inflammation reduction, tissue repair, and the effective elimination of chronic knee pain. The second is Anti-Cancer Therapy (ACT), which employs patented light-activated Photo Dynamic Compounds (PDCs) combined with laser technology for destructive applications, specifically targeting the safe and effective destruction of cancer, bacteria, and viruses.

Recent filings

Filing Released Lang Actions
Material change report - English.pdf
Capital/Financing Update Classification · 88% confidence The document is a Canadian Form 51-102F3 Material Change Report disclosing the closing of a non-brokered private placement, detailing issuance of units, common shares, warrants, related‐party subscriptions and the use of proceeds. This is a direct update on the company’s financing activity and capital structure. It is not simply a notice of report publication, an earnings release, or a proxy statement, but an actual fundraising update. Therefore it best fits the Capital/Financing Update category (CAP).
2025-07-07 English
News release - English.pdf
Share Issue/Capital Change Classification · 85% confidence The document is a press release announcing an extension of the expiry date of existing share purchase warrants, which constitutes a change to the company’s capital structure (exercise rights and timelines). This falls under announcements of share issues or capital changes rather than an earnings release, management change, or regulatory filing. Therefore, it should be classified as a Share Issue/Capital Change (SHA).
2025-07-01 English
Report of exempt distribution (45-106F1).pdf
Regulatory Filings
2025-06-23 English
News release - English.pdf
Capital/Financing Update Classification · 85% confidence The document is a corporate press release announcing the closing of a non-brokered private placement, detailing the number of units issued, subscription price, use of proceeds, related party transactions, and TSXV acceptance. This is clearly an update on company fundraising and capital structure changes, fitting the definition of a Capital/Financing Update (CAP).
2025-06-17 English
News release - English.pdf
Regulatory Filings
2025-06-12 English
News release - English.pdf
AGM Information Classification · 87% confidence The document is a press release reminding shareholders of the upcoming Annual General and Special Meeting (AGSM) with details on date, time, location, virtual attendance options, and the corporate presentation agenda. It does not present financial results or votes, nor is it a full report. It clearly relates to AGM logistics and materials. Therefore, it falls under AGM Information (AGM-R).
2025-06-05 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.